Assessment of multiparametric MRI in a human glioma model to monitor cytotoxic and anti-angiogenic drug effects - Wikidata - wikimedia - TriplyDB

Assessment of multiparametric MRI in a human glioma model to monitor cytotoxic and anti-angiogenic drug effects

Assessment of multiparametric MRI in a human glioma model to monitor cytotoxic and anti-angiogenic drug effects

http://www.wikidata.org/entity/Q33933312

about

Distribution and radiosensitizing effect of cholesterol-coupled Dbait molecule in rat model of glioblastoma Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients Practical dynamic contrast enhanced MRI in small animal models of cancer: data acquisition, data analysis, and interpretation A simulation tool for dynamic contrast enhanced MRI.Vessel caliber--a potential MRI biomarker of tumour response in clinical trials.Clinical applications of iron oxide nanoparticles for magnetic resonance imaging of brain tumors.MRI biomarkers identify the differential response of glioblastoma multiforme to anti-angiogenic therapy.Overexpression of miRNA-497 inhibits tumor angiogenesis by targeting VEGFR2.Perfluorocarbon-Loaded Lipid Nanocapsules to Assess the Dependence of U87-Human Glioblastoma Tumor pO2 on In Vitro Expansion Conditions.Detection of glioblastoma response to temozolomide combined with bevacizumab based on μMRI and μPET imaging reveals [18F]-fluoro-L-thymidine as an early and robust predictive marker for treatment efficacy.MRI measurements of vessel calibre in tumour xenografts: comparison with vascular corrosion casting Assessing the reproducibility of dynamic contrast enhanced magnetic resonance imaging in a murine model of breast cancer.Diffusion-Weighted MRI as a Biomarker of Tumor Radiation Treatment Response Heterogeneity: A Comparative Study of Whole-Volume Histogram Analysis versus Voxel-Based Functional Diffusion Map Analysis Imaging the microvessel caliber and density: Principles and applications of microvascular MRI.Functional MRI and CT biomarkers in oncology.Microvascular MRI and unsupervised clustering yields histology-resembling images in two rat models of glioma.Vessel size index measurements in a rat model of glioma: comparison of the dynamic (Gd) and steady-state (iron-oxide) susceptibility contrast MRI approaches.Characterization of the serum metabolome following radiation treatment in patients with high-grade gliomas.Tissue oxygen saturation mapping with magnetic resonance imaging.Characterization of the 9L gliosarcoma implanted in the Fischer rat: an orthotopic model for a grade IV brain tumor.High-resolution cerebral blood volume imaging in humans using the blood pool contrast agent ferumoxytol.Dynamic contrast-enhanced MRI in mouse tumors at 11.7 T: comparison of three contrast agents with different molecular weights to assess the early effects of combretastatin A4.Multiparametric MRI as an early biomarker of individual therapy effects during concomitant treatment of brain tumours.

P2860

Q21560786-8D802BB7-0C64-4D60-9637-F3D1DA965148 Q26853308-002E7CD0-3CFE-451D-8B54-2209E5AF37EB Q30575110-2DDAA35B-59D0-4E50-BBE0-AD32C8112CA5 Q30604706-DD74E5AC-3433-4BAB-900D-84F503F4C733 Q30651792-5E00A4A0-35C6-491C-8F14-F69127C0DE58 Q30930526-D448FC95-2418-4663-B6B0-2BCEFB9EEEC8 Q33616649-8E902F05-19FC-4AAE-A627-E3E9F8342675 Q36033915-38CCCCDA-A287-4051-BD2F-AC7380DD0F67 Q36176340-5477BFA0-63E5-4D6C-855F-B09E72671BF2 Q36500372-D4DECEE5-D365-4E79-9C0A-F6B46DBF2E56 Q36852895-F954CFB1-2B25-4989-ACFD-6D2972356196 Q37088411-38BCD3F7-A9DA-40E4-9B25-E2AE9B002ADF Q37236015-F8085BEB-33BF-452F-BEEB-D8ED904FD4DC Q38244289-1887D18E-59E4-495E-8246-3D6ABA1A63E9 Q38314429-A37499CD-D90E-42FB-8B7B-C5699C562136 Q38992908-16F954AC-24E9-4BCF-8BCF-A2598FFF6D09 Q39507583-E8E71376-FA42-44EE-890E-29D1EE52C083 Q39817583-EE95E3F1-3992-429F-AA95-170DAE604DD8 Q42870267-1032AF5F-6DC0-4B9E-9099-F7D19393DC98 Q43447982-22E0B559-5DB3-42DF-9946-16A57854533E Q46842885-244D9A7F-EAE2-42D3-8731-9B64D7B8D206 Q52654441-8655146D-A2A4-40FB-94D5-B802459B9840 Q53829611-E87B0BDF-87BB-4E8D-BF33-04E53B186677

P2860

Assessment of multiparametric MRI in a human glioma model to monitor cytotoxic and anti-angiogenic drug effects

http://www.wikidata.org/entity/Q33933312

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Assessment of multiparametric ...... d anti-angiogenic drug effects

@ast

Assessment of multiparametric ...... d anti-angiogenic drug effects

@en

type

label

Assessment of multiparametric ...... d anti-angiogenic drug effects

@ast

Assessment of multiparametric ...... d anti-angiogenic drug effects

@en

prefLabel

Assessment of multiparametric ...... d anti-angiogenic drug effects

@ast

Assessment of multiparametric ...... d anti-angiogenic drug effects

@en

P1433

Q33933312-1C815950-9015-4000-8405-C3614469C4C1

P1476

Q33933312-E9F9ABAF-6BD3-49A0-B6BE-0EBC439B3D60

P2093

Q33933312-0887C954-E832-452D-AB5D-398A53FC653A

Q33933312-09CB411D-7319-4E91-B6A2-F968F455E283

Q33933312-3A0D0F1F-FC55-46F0-AF27-FAD501EAF30E

Q33933312-4A75431F-BC7B-49A9-80A8-06C9D080FF86

Q33933312-65EABD3D-F3C6-4C05-90C2-28302FDB7E79

Q33933312-707471EB-AE24-4B10-AD9E-555094B4B33C

Q33933312-8E0DE4F0-1023-4915-ADAA-A673761F6073

Q33933312-BBA76762-83E9-4592-9C23-E01AE8A75F97

Q33933312-C50559F6-51B0-4700-8D5F-C5E51D2CD688

Q33933312-EA4044C1-CC28-4D81-BFD8-E2B9F7BB80CB

P2860

Q33933312-13CE4182-7C7C-4B73-B96E-ED9CC63FDE35

Q33933312-2704ECE3-9701-48C8-AECF-F4A8F1FBC0C7

Q33933312-2AAE0955-2B9A-4921-94FD-405F32A61609

Q33933312-2E4A2394-1EA6-4ED4-9CE7-80DC9215666B

Q33933312-35C146A3-CD95-4B26-98EC-CA97504A0A04

Q33933312-3D8B4A92-450F-400F-A59E-DB84B3510665

Q33933312-4314DB4E-EAEE-4F3B-8723-909F6D09A7A0

Q33933312-58C2D35D-9ECA-4F24-850C-39A56FCEBE52

Q33933312-65F12040-B9F7-44F5-A0FE-1FB66E0BA592

Q33933312-71211F29-86BE-4FD7-B059-89F7110495BF

P304

Q33933312-742F9487-4CFA-4096-A993-DF51EA9A192C

P31

Q33933312-EC93D9FC-6C93-4BB5-97A2-78B8C70E332F

P356

Q33933312-EF87B4E3-F405-4ABC-9310-587A4D08FA8C

P433

Q33933312-2403DD41-30A4-4A18-941D-ED247D978D76

P478

Q33933312-EFE7D396-F7C4-448F-83E7-CAB08A88C269

P577

Q33933312-D4A68E54-C925-4DF9-8F50-B7846606B670

P5875

Q33933312-7451AC7C-1714-472D-95D0-4094E766593A

P698

Q33933312-DFD965DF-1C5B-407F-89E6-8E32238ABFFC

P921

Q33933312-D86C3103-0AEF-42ED-934C-BAF8BD96F288

P932

Q33933312-041CB312-11CB-45CA-B471-BBC2C83F967B

P356

P1433

NMR in Biomedicine

P1476

Assessment of multiparametric ...... d anti-angiogenic drug effects

@en

P2093

Benjamin Lemasson

http://www.w3.org/2001/XMLSchema#string

Chantal Remy

http://www.w3.org/2001/XMLSchema#string

Christoph Segebarth

http://www.w3.org/2001/XMLSchema#string

Emmanuel L Barbier

http://www.w3.org/2001/XMLSchema#string

Nadège Fondraz

http://www.w3.org/2001/XMLSchema#string

Olivier Duchamp

http://www.w3.org/2001/XMLSchema#string

Peggy Provent

http://www.w3.org/2001/XMLSchema#string

Philippe Genne

http://www.w3.org/2001/XMLSchema#string

Régine Farion

http://www.w3.org/2001/XMLSchema#string

Thomas Christen

http://www.w3.org/2001/XMLSchema#string

P2860

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

Role of angiogenesis in tumor growth and metastasis

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

A "vascular normalization index" as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients.

Methodology of brain perfusion imaging.

Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma.

Angiogenesis in gliomas: imaging and experimental therapeutics.

Diffusion-weighted MRI in the body: applications and challenges in oncology.

MRI of tumor angiogenesis.

Biomarkers of response and resistance to antiangiogenic therapy.

P304

473-482

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/NBM.1611

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51220619

http://www.w3.org/2001/XMLSchema#string

P698

21674650

http://www.w3.org/2001/XMLSchema#string

P921

P932

3351072

http://www.w3.org/2001/XMLSchema#string